Sign In



Remember Me

MedlinePlus®

A service of the National Library of Medicine.

MerckSource received the 2006 WebAward for Outstanding Website Development from the Web Marketing Association at the annual WebAward competition.






MerckSource was honored at the Healthcare Internet Conference in Atlanta, receiving the 2006 Gold eHealthcare Leadership Award for best health/healthcare content.






MerckSource received the 2006 WWW site Award of Excellence from the Health Improvement Institute.  This award honors excellence in health communications.






More Awards

Resource Library


Powered by:  

This information is provided by an independent source. Merck & Co., Inc. is not responsible for this content. Please discuss any and all treatment options with your healthcare professional. The manufacturer of a product generally has the most complete information about that product.

What Is Skin Cancer?

As the body's largest organ, your skin performs a variety of functions. It protects against infection, stores water, helps regulate body temperature and converts sunlight into vitamin D.

To the naked eye, the skin appears as a thin sheath. It weighs a mere six pounds, on average. Yet, the skin is a highly complex organ comprised of two main layers: the inner dermis and outer epidermis. Each layer contains several different kinds of cells.

When skin cells begin to grow and divide uncontrollably, the result is skin cancer. There are several forms of skin cancer, and they are classified under two broad categories: non-melanoma skin cancer (NMSC) and melanoma.

The two major forms of NMSC are basal cell carcinoma and squamous cell carcinoma ("carcinoma" is a medical term for cancer). Both arise from cells in the epidermis and are rarely lifethreatening.

The most dangerous form of skin cancer is malignant melanoma, which arises from pigment-producing cells (melanocytes) in the dermis and kills thousands of Americans every year.

Basal cell carcinoma

This most common form of skin cancer accounts for 75 percent to 80 percent of skin cancer cases. Basal cell carcinoma forms in the deepest layer (basal cell layer) of the epidermis and grows very slowly, usually on chronically sun-exposed areas of skin, such as the nose, cheeks, neck, and forearms.

According to the American Cancer Society (ACS), basal cell carcinoma used to occur almost exclusively in middle-aged or older patients. Today, younger people are being diagnosed with the disease, probably owing to increased sun exposure.

Squamous cell carcinoma

Sixteen percent to 20 percent of skin cancers are squamous cell carcinomas, which arise in higher levels of the epidermis. Like basal cell carcinomas, squamous cell cancers typically appear on sun-exposed areas: the face, ears, neck, lips, or back of the hands. Squamous cell carcinomas also can grow within scars or skin ulcers.

Squamous cell carcinomas are more likely than basal cell carcinomas to spread to tissues beneath the skin and to distant parts of the body. Fortunately, it is very rare for a squamous cell or basal cell carcinoma to spread to lymph nodes or other organs. They nevertheless should be removed as soon as possible after they are discovered; treatment of advanced NMSCs can leave disfiguring scars. About 1200 Americans died of squamous cell carcinoma in 1998.

Melanoma

Only four percent of skin cancer cases are melanomas, yet this aggressive disease is responsible for almost 79 percent of all skin-cancer deaths, according to the ACS. The U.S. Centers for Disease Control and Prevention (CDC) ranks malignant melanoma as the most rapidly increasing form of cancer in the United States. A melanoma can spread to other organs, usually the lungs and liver, unless it is diagnosed and properly treated at an early stage.

There are several less common forms of non-melanoma skin cancer, including Kaposi's sarcoma (usually associated with AIDS), Merkel cell carcinoma, and cutaneous lymphoma. Collectively, all these account for less than one percent of non-melanoma skin cancers diagnosed in the United States, according to ACS statistics.

External Resources:

American Cancer Society

US Centers for Disease Control and Prevention

American Academy of Dermatology

This article was reviewed by Simeon Margolis, M.D., Ph.D.
Professor of Medicine, Endocrinology and Biological Chemistry
The Johns Hopkins University School of Medicine
01/2003

Return to the previous page

This article was published on 1999-11-05
This article was reviewed on 2003-02-03

    Print This Page   Add To My Folder  

20351091(1)-12/03-EBS-CON